Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"PX-866"”.

  1. Joint Intervention in Opposing Pathways, PI3K/Akt and TGF-beta, with PX-866 and Raloxifene, to Alter Gene Expression and Suppress Estrogen Receptor-positive Breast Cancer Cell Proliferation

    … the TGF-beta pathway in combination with PX-866 to down-regulate the PI3K/Akt pathway in estrogen receptor expressing MCF-7 breast cancer cells. I evaluated upstream and downstream effects that led to decreased cell cycle proliferation, including expression and protein modification …

    uab Repository record for Joint Intervention in Opposing Pathways, PI3K/Akt and TGF-beta, with PX-866 and Raloxifene, to Alter Gene Expression and Suppress Estrogen Receptor-positive Breast Cancer Cell Proliferation (opens in a new tab)

  2. The Influence of Adenoviral Infection and the Group VIA Calcium-Independent Phospholipase A2 on Hepatic Lipid Metabolism

    … phosphatidylinositol 3-kinase (PI3K) inhibitor, PX-866, suppressed Ad-5-induced SRBEP1 expression and hypertriglyceridemia implicating the PI3K/Akt pathway in Ad-5 activation of SREBP1. Use of PX-866 led to the discovery of a third mechanism of SREBP1 regulation. In vivo studies demonstrate that …

    vcu Repository record for The Influence of Adenoviral Infection and the Group VIA Calcium-Independent Phospholipase A2 on Hepatic Lipid Metabolism (opens in a new tab)

  3. Magnetic Resonance Imaging Biomarkers For Targeted Cancer Therapies

    … biomarkers in identifying early response to PX-866, a PI3K inhibitor, in ACC-3199 tumors as represented by changes in tumor cellularity and hemodynamic parameters, respectively. Our results indicated that DW-MRI was able to identify an early response to PX-886 in ACC-3199 tumors as defined by …

    arizona-thes Repository record for Magnetic Resonance Imaging Biomarkers For Targeted Cancer Therapies (opens in a new tab)